drugset / Trial / NCT06579482

Clinical Trial of Aesculus Hippocastanum and Associations Versus Diosmina and Hesperidina in Chronic Venous Insuficiency

NCT06579482

Phase 4 Completed 120 enrolled Fundação Educacional Serra dos Órgãos
RandomizedParallel-groupTriple-blindTreatment

Summary

To demonstrate the clinical non-inferiority of efficacy between Aesculus hippocastanum, Polygonum acre, Smilax Pepyracea, Rutin and Diosmin 450mg and Hesperidin 50mg tablets in the improvement of lower limb symptoms assessed by means of a 100mm visual scale (VAS) over 3 months among adult patients presenting with chronic venous insufficiency of the lower limbs.

Timeline

Start
2024-11-06
Primary completion
2025-05-05
Completion
2025-06-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Diosmin Small molecule 450 mg
Subject Hesperidin Small molecule 50 mg
Subject Horse Chestnut Unknown 50 mg
Subject Polygonum acre Unknown 10 mg
Subject Rutin Unknown 20 mg
Subject Smilax Pepyracea Unknown 40 mg